[Effects of nicardipine in hypertensive patients with chronic kidney insufficiency]. 1990

R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
Università degli Studi di Roma La Sapienza.

There has been a increasing awareness that calcium antagonists may have beneficial effects on the kidney. Therefore we evaluated the renal and antihypertensive effects of nicardipine treatment in 12 hypertensive patients with chronic renal failure. The drug was given at a dose of 20 mg three times a day. Blood pressure was normalized in almost all cases while the indexes of renal function were improved. A transient deterioration of renal function, probably due to reduction of glomerular capillary pressure was observed in some cases. In conclusion, our data showed a beneficial effect on renal function during nicardipine therapy. This effect could be absent in the most advanced degree of renal damage.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009529 Nicardipine A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. Antagonil,Cardene,Cardene I.V.,Cardene SR,Dagan,Flusemide,Lecibral,Lincil,Loxen,Lucenfal,Nicardipine Hydrochloride,Nicardipine LA,Nicardipino Ratiopharm,Nicardipino Seid,Perdipine,Ridene,Vasonase,Y-93,Hydrochloride, Nicardipine,LA, Nicardipine,Y 93,Y93
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
January 1988, Archivio Monaldi per le malattie del torace,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
January 1990, Journal of cardiovascular pharmacology,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
April 1984, Lijecnicki vjesnik,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
February 1986, Medicina clinica,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
February 1990, Journal of clinical pharmacology,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
January 1970, Urologiia i nefrologiia,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
November 2007, Journal of hypertension,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
January 1988, Giornale di clinica medica,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
May 2008, Hypertension research : official journal of the Japanese Society of Hypertension,
R Leonetti Luparini, and C Giarrizzo, and R Onofri, and C Ferri, and A Caparra, and G Germanò, and A Santucci
September 1973, Zeitschrift fur Urologie und Nephrologie,
Copied contents to your clipboard!